Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1420 ARTÍCULOS , VIENDO DEL 886 AL 900

The GPCR Connection: Linking Alzheimer's Disease and Glioblastoma

Caniceiro AB, Agostinho SP, Piochi LF, Rosário-Ferreira N, Moreira IS.

J Cell Mol Med. 2026 Apr;30(7):e71131. doi: 10.1111/jcmm.71131.

Efficacy, safety, and ARIA risk of anti-β-amyloid antibodies in early Alzheimer's disease: a systematic review, meta-analysis, and meta-regression

da Silva AMP, de Deus O, Januário Campos Cardoso L, Virgilio Ribeiro F, Froelich Meldola P, Rodrigues Menezes I, Lee Han M, Quiroga DG, James Almeida K, Haddad Santos D, Perry G, Høilund-Carlsen PF, de Souza Franco E, de Sousa Maia MB.

Expert Opin Biol Ther. 2026 Jan-Feb;26(2):177-188. doi: 10.1080/14712598.2026.2631536. Epub 2026 Feb 14.

Glycocalyx and basal lamina in neurological disorders

Nasrollahi A, Yurchenco PD, Yao Y.

Matrix Biol. 2026 Jun;146:102015. doi: 10.1016/j.matbio.2026.102015. Epub 2026 May 12.

Tau phosphorylation homeostasis: Mechanisms, targets, and therapeutic implications in Alzheimer's disease

Lu S, Qiu S, Guan Y, Zhang A, Zhao Q.

Ageing Res Rev. 2026 Jun;118:103097. doi: 10.1016/j.arr.2026.103097. Epub 2026 Mar 18.

Hallucinogenic Therapy in Alzheimer's Disease targeting Mitochondria-Associated Membranes

Minauro-Sanmiguel F, Vargas-Perez H.

Neuroscience. 2026 Apr 6;599:162-169. doi: 10.1016/j.neuroscience.2026.02.028. Epub 2026 Feb 16.

Reprogramming aging astrocytes in Alzheimer's disease

Alfonso-Triguero M, Arranz AM.

Trends Neurosci. 2026 Apr;49(4):251-253. doi: 10.1016/j.tins.2026.03.002. Epub 2026 Mar 31.

Brain peptides in Alzheimer's disease - pathophysiology and therapeutic advances

Pahal S, Gupta A, Kumar V, Singh P, Kaushik M, Pahal V, Atluri G, Chaudhary A.

Cell Tissue Res. 2026 Mar 3;403(3):28. doi: 10.1007/s00441-026-04055-8.

Wake-promoting neuromodulators in Alzheimer's disease: Implications for sleep and brain clearance

Pedersen TJ, Clemens SG, Winer JR, Sharma A, Falgàs N, Lucey BP, Gordon BA, Musiek ES.

Alzheimers Dement. 2026 Mar;22(3):e71298. doi: 10.1002/alz.71298.

Drug repurposing in Alzheimer's disease: Emerging therapeutic strategies and promising candidates

More PS, Rangari SW, Lade SN, Unidrwade DS, Burle SS, Umekar MJ, Lohiya RT, Zanwar AS.

Ageing Res Rev. 2026 Jun;118:103113. doi: 10.1016/j.arr.2026.103113. Epub 2026 Apr 7.

Musicality is Preserved in Neurodegeneration

Moret S, Galbraith JA, Lorenzon G, Mehr SA, Fredericks CA.

Yale J Biol Med. 2026 Mar 31;99(1):243-256. doi: 10.59249/JUOP3641. eCollection 2026 Mar.

Traditional Chinese Medicine and Ferroptosis in Alzheimer's Disease: A Potential Therapeutic Approach

Liu A, Xing L, Li J, Yao M, Song J, Guo W, Duan P, Li H.

Drug Des Devel Ther. 2026 Mar 9;20:590868. doi: 10.2147/DDDT.S590868. eCollection 2026.

[New therapies and ongoing clinical trials in Alzheimer's disease]

Andersen P, Bonnard A, Börjesson Hanson A, Kivipelto M.

Lakartidningen. 2026 May 20;123:25147.

Akkermansia muciniphila and Alzheimer's Disease: Mechanisms, Evidence and Translational Potential

Li J, Long Q, Zhu B.

Biomolecules. 2026 May 15;16(5):726. doi: 10.3390/biom16050726.

The Interplay Between Immunometabolism and Neuroinflammation in Alzheimer's Disease

Di Crescenzo T, Papiri G, Membrino V, Alia S, Cecati M, Campagna R, Silvestrini M, Luzzi S, Vignini A.

Biomolecules. 2026 Apr 28;16(5):656. doi: 10.3390/biom16050656.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias